Özet:

Breast cancer is the most common type of cancer in women worldwide. In the treatment of breast cancer in general, in addition to surgical treatment, adjuvant systemic treatment and radiotherapy is applied when necessary. In the treatment of breast cancer, neoadjuvan chemotherapy is used to reduce the size of the tumor in the local advanced operable breast cancer with the possibility of breast protection surgery and to reduce the need for disection of acne. In the treatment of inflammatory breast cancer and inoperable breast cancer, adjuvan chemotherapy is used to increase the overall survival time and delay the progression of the disease while removing symptoms. Neoadjuvan chemotherapy for breast cancer is a new strategy that emerged at the end of the 20th century and is increasingly used in breast cancer treatment. Currently, neoadjuvan chemotherapy is increasingly used to provide a limited approach to abstracts in patients with both local advanced and operable breast cancer and to make large tumor patients suitable for breast protection surgery. Breast-protection procedures are more preferred by surgeons today, and the post-chemotherapy sub-sitting disection is replaced by the synthetic lymph nodus biopsy. One of the objectives of Neoadjuvan systemic treatment is to try to do a less aggressive breast-protection surgery, primarily for cosmetic reasons, and to preserve the movement of the arms, avoiding the risk of pain and lymphodema. Another objective of neoadjuvan systemic treatment is to see the response the tumor gives to chemotherapy and to determine the treatment accordingly. Neoadjuvan systemic treatment increases the full pathological response rate by cleansing the pre-chirurgical breast and subsequent area from the tumor cells. In this collection, we discussed the important points in neoadjuvan chemotherapy in breast cancer, the methods of post-adjuvan chemotherapy radiological imaging, surgical treatment and reconstruction. (SETB 2020-11-235)

Anahtar Kelimeler: